Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 18,445,000 | 9,137,640 | 8,514,750 | 8,376,000 | 19,076,920 |
| Cost of Goods | 15,888,000 | 7,509,120 | 6,868,850 | N/A | 6,454,300 |
| Gross Profit | 2,557,000 | 1,628,520 | 1,645,900 | 8,376,000 | 12,622,620 |
| Operating Expenses | 0 | 120 | 850 | 0 | 8,865,680 |
| Operating Income | 2,557,000 | 1,628,520 | 1,645,900 | 8,376,000 | 3,757,240 |
| Interest Expense | 1,013,000 | 59,700 | 16,390 | 0 | 0 |
| Other Income | 419,000 | 164,180 | 142,620 | 0 | 492,960 |
| Pre-tax Income | 1,963,000 | 1,733,000 | 1,772,130 | 8,376,000 | 4,250,200 |
| Income Tax | 815,000 | 547,260 | 565,570 | N/A | 1,276,640 |
| Net Income Continuous | 2,508,000 | 2,471,000 | 1,197,711 | 1,030,407 | 909,000 |
| Net Income | $1,143,000 | $1,184,080 | $1,196,720 | $1,004,000 | $2,934,060 |
| EPS Basic Total Ops | 0.32 | 0.74 | 0.63 | 0.55 | 0.48 |
| EPS Basic Continuous Ops | 0.71 | 0.69 | 0.63 | 0.54 | 0.48 |
| EPS Diluted Total Ops | 0.32 | 0.73 | 0.63 | 0.55 | 0.48 |
| EPS Diluted Continuous Ops | 0.70 | 0.69 | 0.63 | 0.54 | 0.48 |
| EBITDA(a) | $2,557,000 | $1,628,520 | $1,645,900 | $8,376,000 | $3,757,240 |